Welcome to the Concord Monitor’s collection of puzzles. In this space, you can put away your scratch pad and your pencil sharpener and jump into a new world of digital puzzles. Instead ...

Please verify your email address. Your browser does not support the video tag. Puzzle games are perfect for those who like to get their brain working, whether it's ...

My ideas come from my dreams, so that’s why I nap so frequently. I’m working.

He's also the crossword editor of The New York Times, the former editor of Games magazine, and the founder and director of the American Crossword Puzzle Tournament (since 1978). Will sold his ...

This year, pharmaceutical giant Merck (NYSE: MRK) is it: The drugmaker's shares are down by 2% in 2024 while the broader S&P 500 is up by 21%. Even when we zoom out, Merck hasn't performed ...

As a teenager, Jasmine said she walked around The Merk thinking someday she'd open her own shop in the historic building. Recently, she found out from a vendor friend that a space was open ...

Are you a print subscriber? Activate your account. By Garett Sloane - 2 hours 35 min ago By Gillian Follett - 2 hours 35 min ago By E.J. Schultz - 2 hours 35 min ago By Jack Neff - 2 hours 35 min ...

There is no Morningstar’s Analysis data available. We sell different types of products and services to both investment professionals and individual investors. These products and services are ...

Merck KGaA’sMRK-1.94%decrease; red down pointing triangle shares jumped after the German company said booming artificial-intelligence demand would help its electronics sales grow faster than ...

Merck booked just under $600 million last year in alliance revenues from the pair, but its attention is now moving to new therapies including sotatercept, a TGF-beta-targeting PAH drug Merck ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

German pharma and technology giant Merck has announced a €5 million (£4.2m) investment in Scotland that will create further jobs at its diagnostics and blood typing facility in Livingston.